Abstract:Hand-foot-and-mouth disease (HFMD) caused by human enterovirus A71 (EV-A71) infection has been associated with severe neurological complications. With the lack of an internationally approved antiviral, coupled with a surge in outbreaks globally, EV-A71 has emerged as a neurotropic virus of high clinical importance. Andrographolide has many pharmacological effects including antiviral activity and its derivative, andrographolide sulfonate, has been used in China clinically to treat EV-A71 infections. This study sought to identify novel andrographolide derivatives as EV-A71 inhibitors and elucidate their antiviral mode of action. Using an immunofluorescence-based phenotypic screen, we identified novel EV-A71 inhibitors from a 344-compound library of andrographolide derivatives and validated them with viral plaque assays. Among these hits, ZAF-47, a quinolinoxy-andrographolide, was selected for downstream mechanistic studies. It was found that ZAF-47 acts on EV-A71 post-entry stages and inhibits EV-A71 protein expression. Subsequent luciferase studies confirm that ZAF-47 targets EV-A71 genome RNA replication specifically. Unsuccessful attempts in generating resistant mutants led us to believe a host factor is likely to be involved which coincide with the finding that ZAF-47 exhibits broad-spectrum antiviral activity against other enteroviruses (CV-A16, CV-A6, Echo7, CV-B5, CV-A24 and EV-D68). Furthermore, ZAF-46 and ZAF-47, hits from the screen, were derivatives of the same series containing quinolinoxy and olefin modifications, suggesting that an andrographolide scaffold mounted with these unique moieties could be a potential anti-EV-A71/HFMD strategy.

Synthesis Of N-Benzyl-N-Phenylthiophene-2-Carboxamide Analogues As A Novel Class Of Enterovirus 71 Inhibitors

Synthesis and Antiviral Activity of N-phenylbenzamide Derivatives, a Novel Class of Enterovirus 71 Inhibitors.

Synthesis and Broad Antiviral Activity of Novel 2-Aryl-isoindolin-1-ones Towards Diverse Enterovirus A71 Clinical Isolates

Synthesis and Antiviral Activities of a Novel Class of Thioflavone and Flavonoid Analogues

Identification and Structure–Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors

Antiviral effects and mechanisms against EV71 of the novel 2-benzoxyl-phenylpyridine derivatives

Asymmetric Synthesis of Novel Triazole Derivatives and Their in Vitro Antiviral Activity and Mechanism of Action.

Identification of Dibucaine Derivatives As Novel Potent Enterovirus 2C Helicase Inhibitors: in Vitro, in Vivo, and Combination Therapy Study

Discovery of Aminothiazole Derivatives As Novel Human Enterovirus A71 Capsid Protein Inhibitors

Design, synthesis and evaluation of 2′-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents

Characterization of Three Small Molecule Inhibitors of Enterovirus 71 Identified from Screening of a Library of Natural Products

New Potent EV-A71 Antivirals Targeting Capsid.

Inhibitory Properties of 2-Substituent-1h-benzimidazole-4-carboxamide Derivatives Against Enteroviruses

Synthesis and Structure–activity Relationship of Α-Keto Amides As Enterovirus 71 3C Protease Inhibitors

Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition

Design, Synthesis and Antiviral Activity of Novel EV71 3C Protease Inhibitors

Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo

Discovery of 3-Benzyl-1,3-benzoxazine-2,4-dione Analogues As Allosteric Mitogen-Activated Kinase Kinase (MEK) Inhibitors and Anti-Enterovirus 71 (EV71) Agents.

Inhibition of Enterovirus 71 Replication by an Α-Hydroxy-nitrile Derivative NK-1.9k

An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71